MOMETASONE FUROATE MONOHYDRATE

Generic: MOMETASONE FUROATE MONOHYDRATE

Aurobindo Pharma LimitedManufacturer
NASALRoute
MOMETASONE FUROATE MONOHYDRATEActive Substance
2024-03-18Original Approval

MOMETASONE FUROATE MONOHYDRATE is FDA application ANDA215878, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DYSPNOEA
1,885 reports
2
ASTHMA
1,671 reports
3
DRUG INEFFECTIVE
1,633 reports
4
HEADACHE
1,552 reports
5
COUGH
1,280 reports
6
OFF LABEL USE
1,227 reports
7
FATIGUE
1,191 reports
8
WHEEZING
1,045 reports
9
GASTROOESOPHAGEAL REFLUX DISEASE
1,019 reports
10
PRURITUS
1,018 reports